Deepinder Goyal has shared more details about Temple, his head-worn wearable that he describes as the world’s first “room-deaf” voice AI companion. Unlike conventional voice AI devices that use microphones to capture sound, Temple uses motion sensors to detect the tiny vibrations produced when its wearer speaks and converts them into text. This allows it to pick up the user’s voice without listening to surrounding sounds or conversations. In other words, Temple can hear its wearer, but the room remains silent to it. The device has no microphone, camera or screen, and users can activate it with a double tap. Small vibrations confirm when it starts and stops listening.
Goyal says the AI companion will let users capture thoughts and ideas, set reminders, remember details from conversations and send messages without reaching for their phones. It can also be used to log everyday activities, including meals and workouts, as well as health complaints such as headaches and dizziness. Temple can then build a record of these experiences and offer insights based on the information collected.
The wearable is also being developed as a health tracker. Along with features such as heart rate, heart rate variability (HRV), sleep and VO2 max tracking, the team is working on automatic chewing detection for calorie tracking, snoring pattern monitoring, sleep-position tracking, jaw-clenching detection, REM sleep tracking and continuous core body temperature monitoring. Goyal believes these additional signals could help provide health insights that conventional wrist and finger wearables may miss.
Beyond its features, Goyal has a long-term ambition for Temple. He wants to keep developing the wearable over several generations and eventually see what Temple 20 looks like. Calling it an ambitious project, he said his team is “delusional enough to think we can build this. And we will.” He described Temple as an ongoing research and development project rather than a conventional product, inviting early adopters to be part of its evolution.
The first version, Temple 01, is expected to ship in early 2027 with both AI and health features. It is priced at Rs 85,000. Goyal’s latest announcement comes as the wearable has attracted considerable attention online, with doctors questioning some of its health-related claims.
Why is Temple facing criticism on X?
Temple has become the subject of a public debate after doctors and health experts questioned the science behind its claims. Hepatologist Dr Cyriac Abby Philips, popularly known as The Liver Doc on X, has been among its most vocal critics.
The central concern is whether Temple can accurately measure blood flow inside the brain using a sensor placed against the side of the head. Critics argue that detecting changes in blood flow near the skin does not necessarily mean the device can measure cerebral blood flow. Questions have also been raised about the scientific evidence supporting its proposed biological entropy metric.
The criticism intensified after Temple opened pre-orders in India at Rs 85,000, with doctors questioning whether the product’s claims have been independently validated before consumers are asked to pay for it.
What Deepinder Goyal has said in Temple’s defence
Goyal responded to the criticism in a lengthy post on X on November 5, addressing doctors directly. Rejecting accusations that Temple is a scam, he said the company had already spent $30 million developing the device, including $20 million from his personal funds.
He also pointed to Temple’s 14-day, no-questions-asked return policy, arguing that customers would quickly find out if the product did not work as promised. Goyal maintained that the company believes in its research and methods, adding that preprints and independent studies would provide more scientific validation.
Goyal also clarified that Temple is a fitness and wellness wearable, not a medical device. He said the company would share clinical validation if any of its metrics were clinically validated.
However, his response has not convinced all critics. Philips continued to question the scientific evidence behind the wearable, arguing that investment figures and return policies do not establish whether its brain-related claims are accurate.
Goyal, meanwhile, remains confident about the project. He also hinted that some of Temple’s most groundbreaking features are yet to be made public, adding that some of them have nothing to do with doctors.
– Ends
Leave a Reply